Coagulation profile in primate recipients of porcine xenografts exposed to long-term treatment with high-dose recombinant human antithrombin.

被引：0
|
作者：
Boldrin, M
Gavasso, S
Seveso, M
Tognin, G
Baldan, N
Katopodis, A
Echelard, Y
Rice, T
Pagnan, A
Simioni, P
Cozzi, E
Ancona, E
机构：
[1] CORIT, Padua, Italy
[2] Padua Hosp, Padua, Italy
[3] Univ Padua, I-35100 Padua, Italy
[4] Novartis Pharma AG, Basel, Switzerland
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2004年 / 4卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
321
引用
收藏
页码：245 / 245
页数：1
相关论文
共 50 条
  • [1] Effects of long-term administration of high-dose recombinant human antithrombin in immunosuppressed primate recipients of porcine xenografts
    Calabrese, F
    Cozzi, E
    Simioni, P
    Seveso, M
    Baldan, N
    Valente, M
    Thiene, G
    Ancona, E
    MODERN PATHOLOGY, 2006, 19 : 260A - 260A
  • [2] Effects of long-term administration of high-dose recombinant human antithrombin in Immunosuppressed primate recipients of porcine Xenografts
    Calabrese, F
    Cozzi, E
    Simioni, P
    Seveso, M
    Baldan, N
    Valente, M
    Thiene, G
    Ancona, E
    LABORATORY INVESTIGATION, 2006, 86 : 260A - 260A
  • [3] Effects of long-term administration of high-dose recombinant human antithrombin in immunosuppressed primate recipients of porcine xenografts
    Cozzi, E
    Simioni, P
    Boldrin, M
    Seveso, M
    Calabrese, F
    Baldan, N
    Busetto, R
    Tormene, D
    Gavasso, S
    Castagnaro, M
    Echelard, Y
    Rice, T
    Plebani, M
    Carraro, P
    Bosio, E
    Valente, M
    Pagnan, A
    Thiene, G
    Ancona, E
    TRANSPLANTATION, 2005, 80 (10) : 1501 - 1510
  • [4] Longterm treatment with high dose recombinant human antithrombin in immunosuppressed primate recipients of porcine xenografts
    Boldrin, M
    Gavasso, S
    Seveso, M
    Fadin, M
    Baldan, N
    Rigotti, P
    Carraro, P
    Katapodis, A
    Echelard, Y
    Lideo, L
    Thiene, G
    Pagnan, A
    Simioni, P
    Cozzi, E
    Ancona, E
    XENOTRANSPLANTATION, 2003, 10 (05) : 483 - 483
  • [5] Effect of long-term and high-dose antithrombin supplementation on coagulation and fibrinolysis in patients with severe sepsis
    Hoffmann, JN
    Mühlbayer, D
    Jochum, M
    Inthorn, D
    CRITICAL CARE MEDICINE, 2004, 32 (09) : 1851 - 1859
  • [6] Long-term (>100 days) diabetes reversal in immunosuppressed nonhuman primate recipients of porcine islet xenografts.
    Hering, BJ
    Aasheim, TC
    Graham, ML
    Jie, T
    Ansite, JD
    Nakano, M
    Moran, K
    Li, W
    Kirchhof, N
    Wijkstrom, M
    Schuurman, HJ
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 160 - 161
  • [7] The safety profile of long-term, high-dose intraocular corticosteroid delivery
    Holekamp, NM
    Thomas, MA
    Pearson, A
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2005, 139 (03) : 421 - 428
  • [8] INDUCTION OF PUBERTY - LONG-TERM TREATMENT WITH HIGH-DOSE LHRH
    BROOK, CGD
    DOMBEY, S
    CLINICAL ENDOCRINOLOGY, 1979, 11 (01) : 81 - 87
  • [9] Safety of long-term high-dose minocycline in the treatment of acne
    Goulden, V
    Glass, D
    Cunliffe, WJ
    BRITISH JOURNAL OF DERMATOLOGY, 1996, 134 (04) : 693 - 695
  • [10] Effects of long-term treatment with recombinant human erythropoietin on physiologic inhibitors of coagulation
    Jaar, B
    Denis, A
    Viron, B
    Verdy, E
    Chamma, F
    Siohan, P
    Mignon, F
    AMERICAN JOURNAL OF NEPHROLOGY, 1997, 17 (05) : 399 - 405
12345